Suleika Jaouad's leukemia experience highlights the importance of mindfulness and support networks in managing the disease.
Image courtesy of the U.S. Centers for Disease Control. Over the past 50 years, survival rates for a group of blood cancers known as myelodysplastic syndrome (MDS) have not improved, despite the ...
Myelodysplastic syndrome is an extremely heterogeneous disease, and there is no definitive cure, so these investigators wanted a better understanding of patients’ priorities regarding their care, ...
Blood disorders known as myelodysplastic syndromes/neoplasms (MDS) are difficult to diagnose – and are commonly misdiagnosed – putting patients at increased risk for treatment mistakes and other ...
The study also highlighted disparities in accurate diagnosis of myelodysplastic syndromes (MDS). Demographic and clinical disparities exist in the accurate diagnosis of older patients with ...
FORT MYERS, Fla., Sept. 22, 2025 /PRNewswire/ -- Leveraging its proprietary real-world data, Florida Cancer Specialists & Research Institute, LLC (FCS) has concluded the first study to evaluate the ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. “It looks like, in the low-risk [myelodysplastic ...
Phase II/III Trial of Etoposide and High-Dose Ifosfamide in Newly Diagnosed Metastatic Osteosarcoma: A Pediatric Oncology Group Trial PURPOSE: We report the first large prospective study of children ...
A new national study shows for the first time that people exposed to Agent Orange face a higher risk of developing myelodysplastic syndrome (MDS), tend to develop it earlier, and often have more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback